Stockreport

Recursion to Participate in Upcoming Investor Conferences

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, t [Read more]